These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 1380042)

  • 21. Diversity of PR3-ANCA epitope specificity in Wegener's granulomatosis. Analysis using the biosensor technology.
    Rarok AA; van der Geld YM; Stegeman CA; Limburg PC; Kallenberg CG
    J Clin Immunol; 2003 Nov; 23(6):460-8. PubMed ID: 15031633
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of recombinant proteinase 3, the autoantigen in Wegener's granulomatosis, in insect cells.
    Van der Geld YM; Smook ML; Huitema MG; Harmsen MC; Limburg PC; Kallenberg CG
    J Immunol Methods; 2002 Jun; 264(1-2):195-205. PubMed ID: 12191522
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-neutrophil cytoplasm antibodies can recognize vascular endothelial cell-bound anti-neutrophil cytoplasm antibody-associated autoantigens.
    Savage CO; Gaskin G; Pusey CD; Pearson JD
    Exp Nephrol; 1993; 1(3):190-5. PubMed ID: 7915959
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Wegener's granulomatosis autoantibodies identify a novel diisopropylfluorophosphate-binding protein in the lysosomes of normal human neutrophils.
    Goldschmeding R; van der Schoot CE; ten Bokkel Huinink D; Hack CE; van den Ende ME; Kallenberg CG; von dem Borne AE
    J Clin Invest; 1989 Nov; 84(5):1577-87. PubMed ID: 2681270
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epitope mapping of anti-proteinase 3 and anti-myeloperoxidase antibodies.
    Chang L; Binos S; Savige J
    Clin Exp Immunol; 1995 Oct; 102(1):112-9. PubMed ID: 7554377
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Wegener's granulomatosis--autoimmunity to neutrophil proteinase 3.
    Watorek E; Boratyńska M; Klinger M
    Arch Immunol Ther Exp (Warsz); 2003; 51(3):157-67. PubMed ID: 12894870
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterisation of anti-neutrophil cytoplasmic antibody target antigens using electrophoresis and western blotting techniques.
    Forde AM; Feighery C; Jackson J
    Br J Biomed Sci; 1998 Dec; 55(4):247-52. PubMed ID: 10436539
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of capture ELISA for detection of antineutrophil cytoplasmic antibodies directed against proteinase 3 in Wegener's granulomatosis: first results from a multicentre study.
    Csernok E; Holle J; Hellmich B; Willem J; Tervaert C; Kallenberg CG; Limburg PC; Niles J; Pan G; Specks U; Westman K; Wieslander J; De Groot K; Gross WL
    Rheumatology (Oxford); 2004 Feb; 43(2):174-80. PubMed ID: 14585921
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation, apoptosis, and clearance of neutrophils in Wegener's granulomatosis.
    van Rossum AP; Limburg PC; Kallenberg CG
    Ann N Y Acad Sci; 2005 Jun; 1051():1-11. PubMed ID: 16126939
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Anti-endothelial cell antibody as a marker of disease activity in Wegener's granulomatosis].
    Göbel U; Sima D; Briedigkeit L; Kettritz R; Sönnichsen N; Natusch R
    Z Arztl Fortbild (Jena); 1994 Aug; 88(7-8):541-4. PubMed ID: 7856259
    [No Abstract]   [Full Text] [Related]  

  • 31. Antineutrophil cytoplasmic antibodies to proteinase 3 in Wegener's granulomatosis: epitope analysis using synthetic peptides.
    Van Der Geld YM; Simpelaar A; Van Der Zee R; Tervaert JW; Stegeman CA; Limburg PC; Kallenberg CG
    Kidney Int; 2001 Jan; 59(1):147-59. PubMed ID: 11135067
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selective killing of B-cell hybridomas targeting proteinase 3, Wegener's autoantigen.
    Reiners KS; Hansen HP; Krüssmann A; Schön G; Csernok E; Gross WL; Engert A; Von Strandmann EP
    Immunology; 2004 Jun; 112(2):228-36. PubMed ID: 15147566
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of monoclonal antibodies to proteinase 3 (PR3) as candidate tools for epitope mapping of human anti-PR3 autoantibodies.
    Van Der Geld YM; Limburg PC; Kallenberg CG
    Clin Exp Immunol; 1999 Dec; 118(3):487-96. PubMed ID: 10594572
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autoantibodies to neutrophil cytoplasmic antigens (ANCA) do not bind to polymorphonuclear neutrophils in blood.
    Abdel-Salam B; Iking-Konert C; Schneider M; Andrassy K; Hänsch GM
    Kidney Int; 2004 Sep; 66(3):1009-17. PubMed ID: 15327394
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discrimination and variable impact of ANCA binding to different surface epitopes on proteinase 3, the Wegener's autoantigen.
    Silva F; Hummel AM; Jenne DE; Specks U
    J Autoimmun; 2010 Dec; 35(4):299-308. PubMed ID: 20810247
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A substrate-based approach to convert SerpinB1 into a specific inhibitor of proteinase 3, the Wegener's granulomatosis autoantigen.
    Jégot G; Derache C; Castella S; Lahouassa H; Pitois E; Jourdan ML; Remold-O'Donnell E; Kellenberger C; Gauthier F; Korkmaz B
    FASEB J; 2011 Sep; 25(9):3019-31. PubMed ID: 21670065
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interaction of proteinase 3 with its associated partners: implications in the pathogenesis of Wegener's granulomatosis.
    Witko-Sarsat V; Reuter N; Mouthon L
    Curr Opin Rheumatol; 2010 Jan; 22(1):1-7. PubMed ID: 19881350
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autoantibodies to early endosome antigen (EEA1) produce a staining pattern resembling cytoplasmic anti-neutrophil cytoplasmic antibodies (C-ANCA).
    Selak S; Woodman RC; Fritzler MJ
    Clin Exp Immunol; 2000 Dec; 122(3):493-8. PubMed ID: 11122260
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detachment and cytolysis of human endothelial cells by proteinase 3.
    Ballieux BE; Hiemstra PS; Klar-Mohamad N; Hagen EC; van Es LA; van der Woude FJ; Daha MR
    Eur J Immunol; 1994 Dec; 24(12):3211-5. PubMed ID: 7805749
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epitope mapping of anti-PR3 antibodies using chimeric human/mouse PR3 recombinant proteins.
    Selga D; Segelmark M; Wieslander J; Gunnarsson L; Hellmark T
    Clin Exp Immunol; 2004 Jan; 135(1):164-72. PubMed ID: 14678279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.